Biotech / PharmaPittsburgh
Ocugenix
Biotech / Pharma
Ocugenix is a clinical-stage biopharmaceutical company based in Pittsburgh, PA, developing therapies for angio-fibrotic diseases of the eye by harnessing the body's natural wound-healing processes. In October 2023, the University of Pittsburgh spinout received FDA clearance to begin a safety trial for its macular degeneration treatment.
Founded
Region
Pittsburgh
Investors
People